Teligent Inc (TLGT)

0.4661 -0.01  -1.06% NASDAQ Jul 30, 20:00 USD
View Full Chart
Price Chart
View All TLGT News

News

View All Events

Events

Date Type Description
08/16/2021 Earnings Results Q2 2021 Earnings Results
08/16/2021 16:30 EST Earnings Calls Q2 2021 Earnings Call
05/25/2021 Earnings Results Q1 2021 Earnings Results
05/25/2021 16:30 EST Earnings Calls Q1 2021 Earnings Call
05/04/2021 Earnings Results Q4 2020 Earnings Results
05/04/2021 16:30 EST Earnings Calls Q4 2020 Earnings Call
12/31/2020 Earnings Results Q3 2020 Earnings Results
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • Description: Teligent Inc is a specialty generic pharmaceutical company. Teligent develops, manufactures, and sells (under its own label) topical, injectable, complex, and ophthalmic pharmaceutical products in the U.S. and Canada. The product portfolio consists of hospital-based sterile injectable products and topical products (creams like Synalar and Spectazole; lotions like Kenalog; ointments like Topicort and Kenalog; and topical solutions like Pennsaid and Xylocaine). The company also offers services to the pharmaceutical, over-the-counter, and cosmetic markets.
  • URL: https://www.teligent.com
  • Investor Relations URL: http://teligent.investorroom.com/
  • HQ State/Province: New Jersey
  • Sector: Healthcare
  • Industry: Drug Manufacturers - Specialty & Generic
  • Equity Style: Small Cap/Value
  • Next Earnings Release: Aug. 16, 2021
  • Last Earnings Release: May. 25, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.